Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeysJ H Lin, M Chiba, I W Chen, et al.Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui|July 1, 1991
[Staphylococcal colonization rate on neonatal nares and umbilical cord in a newborn nursery]M Y Chou, K S Lim, T Young, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1995
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urineS K Balani, B H Arison, L Mathai, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1989
The physiological disposition of lovastatinD E Duggan, I W Chen, W F Bayne, et al.Annals of Emergency Medicine|August 1, 1987
Myoglobin as an early indicator of acute myocardial infarctionW B Gibler, C D Gibler, E Weinshenker, et al.Biochemical Pharmacology|August 11, 1998
Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomesM Chiba, J A Nishime, I W Chen, et al.Organic Letters|November 18, 2000
Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferaseC J Dinsmore, C B Zartman, W F Baginsky, et al.Pharmaceutical Research|June 1, 1995
Regiospecific intestinal absorption of the HIV protease inhibitor L-735,524 in beagle dogsG Y Kwei, L B Novak, L A Hettrick, et al.Journal of Medicinal Chemistry|May 23, 1997
Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacyT J Tucker, W C Lumma, S D Lewis, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2000
Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitorsC A Coburn, D M Rush, P D Williams, et al.Pageof 10